INOVIO Pharma Announces Positive Results From Phase 1b Clinical Trial Evaluating INO-4201

RTTNews | 853 दिनों पहले
INOVIO Pharma Announces Positive Results From Phase 1b Clinical Trial Evaluating INO-4201

(RTTNews) - Biotechnology company INOVIO Pharmaceuticals, Inc. (INO) announced Thursday positive results from a Phase 1b clinical trial evaluating INO-4201, a DNA vaccine candidate, as a booster in healthy adult participants who previously received a single injection of Ervebo.

In the trial, INO-4201 was well-tolerated and boosted humoral responses in 100% (36 of 36) of treated participants.

INO-4201 was evaluated in a 46-participant randomized, placebo-controlled Phase 1b trial (NCT04906629) to assess its safety, tolerability, and immunogenicity in healthy adult participants who previously received a single injection of Ervebo, a vaccine approved by the U.S. Food and Drug Administration for the prevention of disease caused by Zaire ebolavirus in individuals 18 years of age and older.

The participants were dosed with 1 mg of INO-4201 injected intradermally followed by electroporation using our investigational proprietary smart device, CELLECTRA. The trial was designed to test whether INO-4201 can be used as a booster in healthy participants previously vaccinated with Ervebo.

For More Such Health News, visit rttnews.com

टैग: INO
read more
Inovio Pharma Receives FDA Feedback On Submission Of BLA For INO-3107 To Treat RRP

Inovio Pharma Receives FDA Feedback On Submission Of BLA For INO-3107 To Treat RRP

Biotechnology company Inovio Pharmaceuticals, Inc. (INO) announced Tuesday that it has received feedback from the U.S. Food and Drug Administration (FDA) that data from its completed Phase 1/2 trial of INO-3107 for the treatment of RRP could support INOVIO's submission of a BLA for review under the FDA's accelerated approval program.
RTTNews | 603 दिनों पहले
Sensex, Nifty Open Higher Ahead Of RBI Meet

Sensex, Nifty Open Higher Ahead Of RBI Meet

Indian shares traded higher on Thursday as weak U.S. economic data reinforced speculation that the Federal Reserve will cut interest rates at least twice this year.
RTTNews | 1घंटे 5 मिनट पहले
European Economic News Preview: ECB To Cut Interest Rates

European Economic News Preview: ECB To Cut Interest Rates

The European Central Bank is widely expected to cut its interest rates on Thursday after inflation fell below the 2 percent target in May. Markets expect the bank to lower the deposit rate by another 25 basis points to 2.00 percent. The bank has reduced the policy rates by a quarter points each in every rate-setting session since September.
RTTNews | 1घंटे 18 मिनट पहले
Australian Market Slips To Slight Losses In Mid-market

Australian Market Slips To Slight Losses In Mid-market

The Australian market is slipping to slight losses in mid-market moves on Thursday after opening in the green, reversing some of the gains in the previous two sessions, following the mixed cues from Wall Street overnight. The benchmark S&P/ASX 200 is staying below the 8,550 level, with by weakness in energy and financial stocks partially offset gains in iron ore miners and some technology stocks.
RTTNews | 1घंटे 58 मिनट पहले
Asian Markets Trade Mostly Higher

Asian Markets Trade Mostly Higher

Asian stock markets are trading mostly higher on Thursday, following the mixed cues from Wall Street overnight, amid optimism about the outlook for interest rates after the release of some weaker than expected U.S. economic data, which raised concerns about the strength of the economy. Asian markets closed mostly higher on Wednesday.
RTTNews | 2घंटे 20 मिनट पहले